Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Mediators of Inflammation|May 31, 2016
Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis PatientsYakov Lomakin, Alexey Belogurov, Irina Glagoleva, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|June 14, 2024
Incautious design of shRNAs for stable overexpression of miRNAs could result in generation of undesired isomiRsDiana Maltseva, Ivan Kirillov, Anton Zhiyanov, et al.
Biochimie|May 11, 2025
Caffeine modulates immunoproteasome activity and content in colorectal adenocarcinoma cellsAlexander Burov, Alexander Rezvykh, Valeria Vedernikova, et al.
The Journal of Biological Chemistry|April 18, 2014
Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradationAlexey Belogurov, Anna Kudriaeva, Ekaterina Kuzina, et al.
Molecules (Basel, Switzerland)|May 16, 2017
The Transcriptome of Type I Murine Astrocytes under Interferon-Gamma Exposure and Remyelination StimulusAnna Kudriaeva, Vladimir V Galatenko, Diana V Maltseva, et al.
International Journal of Molecular Sciences|February 13, 2026
The Critical Role of Steroid Regimen for Lung Repair in Experimental Diffuse Alveolar DamageAleksandr Chernov, Georgii Telegin, Evgeny Sinitsyn, et al.
Scientific Reports|August 25, 2018
Diagnostics of autoimmune neurodegeneration using fluorescent probingYakov Lomakin, Anna Kudriaeva, Nikita Kostin, et al.
Frontiers in Pharmacology|August 21, 2018
QM/MM Description of Newly Selected Catalytic Bioscavengers Against Organophosphorus Compounds Revealed Reactivation Stimulus Mediated by Histidine Residue in the Acyl-Binding LoopAlexander Zlobin, Yuliana Mokrushina, Stanislav Terekhov, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 22, 2016
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation StudyAlexey Belogurov, Konstantin Zakharov, Yakov Lomakin, et al.
Frontiers in Immunology|July 22, 2017
Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In VivoYakov Lomakin, Georgii Pavlovich Arapidi, Alexander Chernov, et al.
Pageof 3